<?xml version="1.0" encoding="UTF-8"?>
<ref id="B269-pharmaceuticals-14-00381">
 <label>269.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ebert</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Dyle</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Bullard</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Dierdorff</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Murry</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Fox</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Bongers</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Lira</surname>
    <given-names>V.A.</given-names>
   </name>
   <name>
    <surname>Meyerholz</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Talley</surname>
    <given-names>J.J.</given-names>
   </name>
  </person-group>
  <article-title>Identification and small molecule inhibition of an activating transcription factor 4 (ATF4)-dependent pathway to age-related skeletal muscle weakness and atrophy</article-title>
  <source>J. Biol. Chem.</source>
  <year>2015</year>
  <volume>290</volume>
  <fpage>25497</fpage>
  <lpage>25511</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.M115.681445</pub-id>
  <pub-id pub-id-type="pmid">26338703</pub-id>
 </element-citation>
</ref>
